SGH
QGENF

Sivik Global Healthcare’s QIAGEN NV QGENF Stock Holding History

Sivik Global Healthcare’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-70,000
Closed -$1.94M – 73
2015
Q4 		$1.94M Buy
+70,000
New +$1.94M 0.92% 51
2014
Q3 		– Sell
-49,451
Closed -$1.21M – 89
2014
Q2 		$1.21M Buy
+49,451
New +$1.21M 0.61% 60

Other funds holding QGENF

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sivik Global Healthcare's QGENF Position: Q1 2016 in Review

Sivik Global Healthcare sold out of QIAGEN NV (QGENF) in Q1 2016, closing a stake of 70,000 shares — an estimated $1.94M sold.

Sivik Global Healthcare first reported a position in QGENF in Q2 2014 and held it in 2 quarters. The position peaked at $1.94M in Q4 2015. 201 funds tracked by Wall St. Rank hold QGENF as of Q1 2016.

  • Sivik Global Healthcare reported no remaining QIAGEN NV position as of Q1 2016 after selling out during the quarter.
  • Sivik Global Healthcare sold 70,000 QIAGEN NV shares in Q1 2016, an estimated $1.94M.
  • Sivik Global Healthcare first reported a position in QIAGEN NV in Q2 2014 and held it in 2 quarters.
  • Sivik Global Healthcare's QIAGEN NV position peaked at $1.94M in Q4 2015.
  • 201 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2016.

Based on Sivik Global Healthcare's 13F filing for Q1 2016, filed 6 May 2016.